ArticleBMC health services research2023

Cost-effectiveness of immune checkpoint inhibition and targeted treatment in combination as adjuvant treatment of patient with BRAF-mutant advanced melanoma.

Si Ni Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.